Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
A novel non-invasive method for using carbon-13 magnetization transfer effects to determine and evaluate in vivo aspartate transaminase (AST) activity and levels in an organ, as a biomarker of disease and certain neurological disorders. More
A rapid and automated method for discovering potential drugs for the treatment of sickle cell anemia, using a combination of laser photolysis and statistical processing of digital images. More
An siRNA type therapeutics delevary system More
This cell line may be used for elucidation of the mechanisms of CF, testing candidate complementary genes for correction of the observed CF abnormalities, and for developing and testing therapeutic CF drugs. More
Improved accuracy in pattern recognition of clustered multidimensional data More
The early detection and treatment of motor developmental delays in infants is critical to future motor skill function. More
A new homogeneous technique which utilizes fluorescence resonance energy transfer (FRET) to directly detect and distinguish specific DNA sequences without requiring either an amplification step or a separation step has been developed. The detection... More
Mismatch-targeted transposition of Mu: a new strategy to map genetic polymorphism. More
A Biomarker for Mucopolysaccharidosis (MPS) Disease: The HCII-T Biomarker is Predictive of the Disease Phenotype and Severity More
Lysosomal acid ceramidase alteration is related to Farber disease and probably to cancer. We offer a fast and sensitive (pmol) fluorimetry method – current methods use radioactivity – to measure its level, with no interferences from other ceramidases More
Related Reports
Market Research Reports provided by reports.innovaro.com
Feb 2011 - 42 pages - $5,700
Apr 2011 - 26 pages - $500
Sep 2010 - 25 pages - $2,000
Oct 2011 - 27 pages - $500
Mar 2011 - 174 pages - $4,795
Nov 2010 - 40 pages - $500
Dec 2010 - 22 pages - $500
Jul 2011 - 136 pages - $500
Apr 2011 - 56 pages - $3,800
Jul 2011 - 39 pages - $5,700
Your selection
- Therapeutic target
- Genetic disorders del
Browse By
- Industry sector
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Pharmaceutical
- Research tools
- Therapeutic target
- Birth defects
- Blood clotting disorders
- Fabry's disease
- Gaucher's disease
- Genetic disorder (other)
- Hunter's syndrome
- Huntington's disease
- Kawasaki disease
- Klinefelter's syndrome
- Phenylketonuria
- Severe combined immunodeficiency
- Turner's syndrome
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us